From article effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients a propensity score matched analysis ther clin risk manag. 2016 xiao bo zhai, zhi-chun gu, and xiao-yan liu
Similar to From article effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients a propensity score matched analysis ther clin risk manag. 2016 xiao bo zhai, zhi-chun gu, and xiao-yan liu
Similar to From article effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients a propensity score matched analysis ther clin risk manag. 2016 xiao bo zhai, zhi-chun gu, and xiao-yan liu (20)
From article effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients a propensity score matched analysis ther clin risk manag. 2016 xiao bo zhai, zhi-chun gu, and xiao-yan liu
1. From :
Ther Clin Risk Manag. 2016; 12: 241–250. Published online 2016 Feb 18.
doi: 10.2147/TCRM.S98300
Effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: a
propensity score-matched analysis
Xiao-bo Zhai,1 Zhi-chun Gu,2 and Xiao-yan Liu2
PMCID: PMC4762444
Conclusion
An experienced senior clinical pharmacist discovered a surprising number of DRPs in a cardiology
ward that were suspected to cause or contribute to the fatal outcome of the patients. Two clinical
pharmacists consulted with the physicians to address these DRPs so that the mortality rate could
be significantly decreased in the cardiology ward. The significant reduction in the mortality rate
should be considered “hypothesis generating” for future randomized studies that will need to
further test the conclusions. A multicenter randomized controlled trial is the best analysis to
demonstrate the effectiveness of this specific intervention.
